Szela Mary T. - 12 Sep 2024 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role: CEO AND PRESIDENT, Director
Signature: /s/ Sean Murphy, Attorney-in-Fact
Issuer symbol: TLSI
Transactions as of: 12 Sep 2024
Net transactions value: +$75,359
Form type: 4
Filing time: 13 Sep 2024, 17:43:14 UTC
Previous filing: 12 Sep 2024
Next filing: 29 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TLSI	Common Stock	Purchase	$39,104	+7,520	+2%	$5.20	377,382	12 Sep 2024	Direct	F1
transaction	TLSI	Common Stock	Purchase	$6,255	+1,295	+0.34%	$4.83	378,677	13 Sep 2024	Direct
transaction	TLSI	Common Stock	Purchase	$30,000	+6,000	+1.6%	$5.00	384,677	13 Sep 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.05 to $5.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.05 to $5.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.